AMERICAN COLLEGE OF ENDOCRINOLOGY AND AMERICAN DIABETES ASSOCIATION CONSENSUS STATEMENT ON INPATIENT DIABETES AND GLYCEMIC CONTROL

2006 ◽  
Vol 12 (4) ◽  
pp. 458-468 ◽  
Author(s):  
ACE/ADA Task Force on Inpatient Diabetes
Diabetes Care ◽  
2009 ◽  
Vol 32 (6) ◽  
pp. 1119-1131 ◽  
Author(s):  
E. S. Moghissi ◽  
M. T. Korytkowski ◽  
M. DiNardo ◽  
D. Einhorn ◽  
R. Hellman ◽  
...  

2009 ◽  
Vol 15 (4) ◽  
pp. 353-369 ◽  
Author(s):  
Etie Moghissi ◽  
Mary Korytkowski ◽  
Monica DiNardo ◽  
Daniel Einhorn ◽  
Richard Hellman ◽  
...  

Diabetes Care ◽  
2021 ◽  
pp. dc203045
Author(s):  
Mary R. Rooney ◽  
Olive Tang ◽  
Justin B. Echouffo Tcheugui ◽  
Pamela L. Lutsey ◽  
Morgan E. Grams ◽  
...  

Diabetology ◽  
2021 ◽  
Vol 2 (4) ◽  
pp. 176-189
Author(s):  
Morgan T. Jones ◽  
Elroy J. Aguiar ◽  
Lee J. Winchester

Individuals with type 1 diabetes suffer from impaired angiogenesis, decreased capillarization, and higher fatigability that influence their muscular system beyond the detriments caused by decreased glycemic control. In order to combat exacerbations of these effects, the American Diabetes Association recommends that individuals with type 1 diabetes participate in regular resistance exercise. However, traditional resistance exercise only induces hypertrophy when loads of ≥65% of an individual’s one repetition maximum are used. Combining blood flow restriction with resistance exercise may serve as a more efficient means for stimulating anabolic pathways that result in increased protein synthesis and angiogenesis at lower loads, while also promoting better glycemic control. The purpose of this paper is to provide a review on the literature surrounding the benefits of resistance exercise, specifically for individuals with type 1 diabetes, and postulate potential effects of combining resistance exercise with blood flow restriction in this clinical population.


2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Jeffrey Nadelson ◽  
Sanjaya K. Satapathy ◽  
Satheesh Nair

Introduction. Aim of this study is to determine if HbA1c levels are a reliable predictor of glycemic control in patients with decompensated cirrhosis.Methods. 200 unique patients referred for liver transplantation at University of Tennessee/Methodist University Transplant Institute with a HbA1c result were included. Three glucose levels prior to the “measured” A1c (MA1c) were input into an HbA1c calculator from the American Diabetes Association website to determine the “calculated” A1c (CA1c). The differences between MA1c and CA1c levels were computed. Patients were divided into three groups: group A, difference of <0.5; group B, 0.51–1.5; and group C, >1.5.Results. 97 (49%) patients had hemoglobin A1c of less than 5%. Discordance between calculated and measured HbA1c of >0.5% was seen in 47% (n=94). Higher level of discordance of greater than >1.5 was in 12% of patients (n=24). Hemoglobin was an independent predictor for higher discordance (odds ratio 0.77 95%, CI 0.60–0.99, andpvalue 0.04). HbA1c was an independent predictor of occurrence of HCC (OR 2.69 955, CI 1.38–5.43, andpvalue 0.008).Conclusion. HbA1c is not a reliable predictor of glycemic control in patients with decompensated cirrhosis, especially in those with severe anemia.


Sign in / Sign up

Export Citation Format

Share Document